Search | IOVS | ARVO Journals

Showing 1 – 20 of 46

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

Deep phenotyping of intermediate age-related macular degeneration (AMD) using rod function tests

Manjot Kaur Grewal; Alan C Bird; Glen Jeffery; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1191. doi:

ARVO Annual Meeting Abstract July 2019

A New Classification for Macular Telangiectasia type 2 based on multi-modal imaging

Emily Y Chew; Tunde Peto; Traci E Clemons; Daniel Pauleikhoff; Ferenc B Sallo; Tjebo Heeren; Catherine A Egan; Peter Charbel Issa; Konstatinos Balaskas; Alan C Bird

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1335. doi:

ARVO Annual Meeting Abstract July 2019

Blue-light reflectance imaging in macular telangiectasia type 2 (MacTel) using two different SLO systems.

Ferenc B Sallo; Vincent Rocco; Irene Leung; Adam M Dubis; Ute EK Wolf-Schnurrbusch; Catherine A Egan; Tunde Peto; Traci E Clemons; Daniel Pauleikhoff; Emily Y Chew; Alan C Bird

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5049. doi:

ARVO Annual Meeting Abstract July 2018

Assessing photoreceptor degeneration in type 2 idiopathic macular telangiectasia.

Ferenc B Sallo; Adam M Dubis; Irene Leung; Traci E Clemons; Daniel Pauleikhoff; Emily Y. Chew; Alan C Bird

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3139. doi:

ARVO Annual Meeting Abstract June 2017

Progression of Ellipsoid Zone Loss correlates with Change of Scotoma Size in Macular Telangiectasia Type 2.

Tjebo FC Heeren; Diána Kitka; Daniela Florea; Alan C Bird; Emily Chew; Traci E Clemons; Daniel Pauleikhoff; Frank G Holz; Tunde Peto

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1280. doi:

ARVO Annual Meeting Abstract June 2017

Distribution and progression patterns of retinal low-reflective intraretinal spaces in Type 2 Idiopathic Macular Telangiectasia.

Ferenc B Sallo; Irene Leung; Ute EK Wolf-Schnurrbusch; Bingqian Liu; Kiyoko Gocho; Valerie Krivosic; Tunde Peto; Adam M Dubis; Daniel Pauleikhoff; Traci E Clemons; Michel Paques; Emily Chew; Alain Gaudric; Alan C Bird

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3687. doi:

ARVO Annual Meeting Abstract September 2016

Functional and structural measures of disease severity from a Phase 1 clinical trial in type 2 idiopathic macular telangiectasia.

Ferenc B Sallo; Irene Leung; Simona Esposti; Traci E Clemons; Daniel Pauleikhoff; Emily Y Chew; Alan C Bird; Tunde Peto

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4955. doi:

Retina June 2015

Progression of Vision Loss in Macular Telangiectasia Type 2

PDF

Tjebo F. C. Heeren; Traci Clemons; Hendrik P. N. Scholl; Alan C. Bird; Frank G. Holz; Peter Charbel Issa
TAGS: blindness, scotoma, telangiectasis, eye
Invest. Ophthalmol. Vis. Sci.. 2015; 56(6):3905-3912. doi: https://doi.org/10.1167/iovs.15-16915

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2015

36-months follow-up of the Phase 1 clinical trial of the use ciliary neurotrophic factor (CNTF) for Macular Telangiectasia Type 2 (MacTel)

Tunde Peto; Traci E Clemons; Emily Y Chew; Irene Leung; Ferenc Sallo; Alan C Bird; MacTel Study Group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1815. doi:

ARVO Annual Meeting Abstract June 2015

Three-dimensional characteristics of outer retinal atrophy in type 2 idiopathic macular telangiectasia.

Ferenc B Sallo; Irene Leung; Vincent Rocco; Meike Zeimer; Britta Heimes; Traci E Clemons; Daniel Pauleikhoff; Emily Y Chew; Alan C Bird; Tunde Peto; MacTel Study Group.

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2783. doi:

ARVO Annual Meeting Abstract April 2014

Progression of Inner Segment/Outer Segment junction breaks in Macular Telangectasia type 2 and association with change in visual acuity over a period of 5 years

Konstantinos Balaskas; Ferenc B Sallo; Irene leung; Traci E Clemons; Emily Y Chew; Alan C Bird; Tunde Peto; MacTel Study Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):4573. doi:

ARVO Annual Meeting Abstract April 2014

Feasibility of microperimetry testing at multiple sites in type 2 idiopathic macular telangiectasia

Stela Vujosevic; Ferenc B Sallo; Irene leung; Daniela Ioana Florea; Daniel Pauleikhoff; Traci E Clemons; Alan C Bird; Tunde Peto; MacTel Study Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5013. doi:

ARVO Annual Meeting Abstract April 2014

Patterns of retinal sensitivity loss in type 2 idiopathic macular telangiectasia (MacTel).

Ferenc B Sallo; Irene Leung; Stela Vujosevic; Traci E Clemons; Alan C Bird; Daniel Pauleikhoff; Tunde Peto; MacTel Study group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5948. doi:

ARVO Annual Meeting Abstract April 2014

Characteristics of pigmented lesions in type 2 idiopathic macular telangiectasia (MacTel).

Irene Leung; Ferenc B Sallo; Daniel Pauleikhoff; Alan C Bird; Traci E Clemons; Tunde Peto; MacTel Study group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5950. doi:

ARVO Annual Meeting Abstract April 2014

A novel mechanism for initiation of sub-RPE deposits

Richard B Thompson; Valentina Reffatto; Jacob Bundy; Jane Flinn; Antonio Lanzirotti; Emrys Jones; David McPhail; Savanjeet Ratu; Alan C Bird; Imre Lengyel

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):623. doi:

ARVO Annual Meeting Abstract April 2014

Comparison of two microperimetry tests in a clincial trial for Macular Telangiectasia Type 2

Tunde Peto; Stela Vujosevic; Ferenc B Sallo; Daniela Florea; Irene Leung; Traci E Clemons; Emily Y Chew; Alan C Bird; MacTel Study Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):674. doi:

Retina November 2012

The IS/OS Junction Layer in the Natural History of Type 2 Idiopathic Macular Telangiectasia

PDF

Ferenc B. Sallo; Tunde Peto; Catherine Egan; Ute E. K. Wolf-Schnurrbusch; Traci E. Clemons; Mark C. Gillies; Daniel Pauleikhoff; Gary S. Rubin; Emily Y. Chew; Alan C. Bird; the MacTel Study Group
TAGS: diagnostic imaging, eye, face, natural history, telangiectasis, retina
Invest. Ophthalmol. Vis. Sci.. 2012; 53(12):7889-7895. doi: https://doi.org/10.1167/iovs.12-10765

Retina September 2012

Macular Pigment Parameters in Patients with Macular Telangiectasia (MacTel) and Normal Subjects: Implications of a Novel Analysis

PDF

Simona Degli Esposti; Catherine Egan; Catey Bunce; Jack D. Moreland; Alan C. Bird; Anthony G. Robson
TAGS: pigment, telangiectasis, complement system proteins
Invest. Ophthalmol. Vis. Sci.. 2012; 53(10):6568-6575. doi: https://doi.org/10.1167/iovs.12-9756

Retina September 2012

“En face” OCT Imaging of the IS/OS Junction Line in Type 2 Idiopathic Macular Telangiectasia

PDF

Ferenc B. Sallo; Tunde Peto; Catherine Egan; Ute E. K. Wolf-Schnurrbusch; Traci E. Clemons; Mark C. Gillies; Daniel Pauleikhoff; Gary S. Rubin; Emily Y. Chew; Alan C. Bird; the MacTel Study Group10
TAGS: diagnostic imaging, eye, face, telangiectasis
Invest. Ophthalmol. Vis. Sci.. 2012; 53(10):6145-6152. doi: https://doi.org/10.1167/iovs.12-10580

ARVO Annual Meeting Abstract March 2012

Agreement Between Time Domain And Spectral Domain OCT In Assessment Of Macular Thickness In Patients With Macular Telangiectasia Type 2

Raeba Mathew; Irene Leung; Ferenc Sallo; Alan C. Bird; Tunde Peto; MacTel Study Group

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):981. doi:

1 2 3

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Deep phenotyping of intermediate age-related macular degeneration (AMD) using rod function tests

A New Classification for Macular Telangiectasia type 2 based on multi-modal imaging

Blue-light reflectance imaging in macular telangiectasia type 2 (MacTel) using two different SLO systems.

Assessing photoreceptor degeneration in type 2 idiopathic macular telangiectasia.

Progression of Ellipsoid Zone Loss correlates with Change of Scotoma Size in Macular Telangiectasia Type 2.

Distribution and progression patterns of retinal low-reflective intraretinal spaces in Type 2 Idiopathic Macular Telangiectasia.

Functional and structural measures of disease severity from a Phase 1 clinical trial in type 2 idiopathic macular telangiectasia.

Progression of Vision Loss in Macular Telangiectasia Type 2

36-months follow-up of the Phase 1 clinical trial of the use ciliary neurotrophic factor (CNTF) for Macular Telangiectasia Type 2 (MacTel)

Three-dimensional characteristics of outer retinal atrophy in type 2 idiopathic macular telangiectasia.

Progression of Inner Segment/Outer Segment junction breaks in Macular Telangectasia type 2 and association with change in visual acuity over a period of 5 years

Feasibility of microperimetry testing at multiple sites in type 2 idiopathic macular telangiectasia

Patterns of retinal sensitivity loss in type 2 idiopathic macular telangiectasia (MacTel).

Characteristics of pigmented lesions in type 2 idiopathic macular telangiectasia (MacTel).

A novel mechanism for initiation of sub-RPE deposits

Comparison of two microperimetry tests in a clincial trial for Macular Telangiectasia Type 2

The IS/OS Junction Layer in the Natural History of Type 2 Idiopathic Macular Telangiectasia

Macular Pigment Parameters in Patients with Macular Telangiectasia (MacTel) and Normal Subjects: Implications of a Novel Analysis

“En face” OCT Imaging of the IS/OS Junction Line in Type 2 Idiopathic Macular Telangiectasia

Agreement Between Time Domain And Spectral Domain OCT In Assessment Of Macular Thickness In Patients With Macular Telangiectasia Type 2

To View More...

You must be signed into an individual account to use this feature.